Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
regulatory T cells
Biotech
Zag Bio emerges with $80M funding for Tregs diabetes candidate
Tregs bio Zag has emerged with backing from biopharma giants AbbVie, Regeneron and Sanofi, which are part of an $80 million series A financing round.
Kevin Dunleavy
Oct 28, 2025 7:00am
Nobel winner turns rogue T cells into their own treatment
Oct 23, 2025 10:35am
How Nobel-winning cells could become a 'universal drug'
Oct 21, 2025 2:00pm
3 scientists win Nobel Prize for discovery of regulatory T cells
Oct 6, 2025 7:03am
Edited T cells allow gluten-sensitive mice to eat grains
Mar 20, 2025 7:16am
Coya shares data on IL-2 prospect in small Alzheimer's study
Oct 29, 2024 7:55am